吉林敖东药业集团股份有限公司第十一届董事会第二十次会议决议公告

Group 1 - The company held its 20th meeting of the 11th Board of Directors on November 6, 2025, with all 9 directors present, including independent directors attending via remote voting [1][3][4] - The meeting approved the proposal regarding the resignation and re-election of an independent director, with a unanimous vote of 9 in favor [3][5] - The company plans to hold its second extraordinary general meeting of shareholders on November 24, 2025, at 14:00 [4][5] Group 2 - The independent director Liang Biming submitted his resignation on November 5, 2025, due to personal reasons, and will continue to fulfill his duties until a new independent director is elected [77][78] - Zhang Chunying has been nominated as the candidate for the independent director position, recommended by the largest shareholder, Dunhua Jincheng Industrial Co., Ltd., which holds 27.35% of the company's shares [78][79] - The independent director candidate must pass the qualification and independence review by the Shenzhen Stock Exchange before the shareholders' meeting can vote on the proposal [79] Group 3 - The company ensures that the notice for the extraordinary general meeting complies with relevant laws and regulations, including the Company Law and the Shenzhen Stock Exchange rules [83] - The meeting will adopt a combination of on-site and online voting methods, with specific voting times outlined [84][86] - Shareholders must register to attend the meeting, with detailed registration procedures provided [93][94]